Citation Impact
Citing Papers
Proliferation and functional maturation of Sertoli cells, and their relevance to disorders of testis function in adulthood
2003 Standout
Etoposide: four decades of development of a topoisomerase II inhibitor
1998 Standout
Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel
2000 Standout
Two-weekly or 3-weekly CHOP chemotherapy with or without etoposide for the treatment of young patients with good-prognosis (normal LDH) aggressive lymphomas: results of the NHL-B1 trial of the DSHNHL
2004
Inhibin B as a Serum Marker of Spermatogenesis: Correlation to Differences in Sperm Concentration and Follicle-Stimulating Hormone Levels. A Study of 349 Danish Men1
1997
ERS/ESTS clinical guidelines on fitness for radical therapy in lung cancer patients (surgery and chemo-radiotherapy)
2009 Standout
Radiation pneumonitis and early circulatory cytokine markers
2002
Hereditary coproporphyria in Germany: clinical-biochemical studies in 53 patients
2000
Amifostine in clinical oncology: current use and future applications
2002
Porphyrias
2010 Standout
Gonadal protection from radiation by GnRH antagonist or recombinant human FSH: a controlled trial in a male nonhuman primate (Macaca fascicularis)
2003
Interleukin (IL)-1A and IL-6: Applications to the predictive diagnostic testing of radiation pneumonitis
2005
Role of the retinoblastoma protein in the pathogenesis of human cancer.
1997 StandoutNobel
RB and cell cycle progression
2006 Standout
Preservation of fertility and ovarian function and minimizing chemotherapy-induced gonadotoxicity in young women
1999
Gemcitabine and paclitaxel associated pneumonitis in non-small cell lung cancer
2000
2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumours
2010 Standout
The pathobiology of mucositis
2004 Standout
Ovarian function preservation in the cancer patient
2004
Cancer treatment and survivorship statistics, 2012
2012 Standout
The Ki-67 protein: From the known and the unknown
2000 Standout
Idarubicin
1991
Elucidation of Lyme arthritis
2004
The Retinoblastoma Gene (RB-1) Status in Multiple Myeloma: A Report on 35 Cases
1995
Lyme borreliosis
2011 Standout
Preservation of Fertility in Patients with Cancer
2009 Standout
ICRP PUBLICATION 118: ICRP Statement on Tissue Reactions and Early and Late Effects of Radiation in Normal Tissues and Organs — Threshold Doses for Tissue Reactions in a Radiation Protection Context
2012 Standout
Retinoblastoma protein family in cell cycle and cancer: A review
1996
The Clinical Assessment, Treatment, and Prevention of Lyme Disease, Human Granulocytic Anaplasmosis, and Babesiosis: Clinical Practice Guidelines by the Infectious Diseases Society of America
2006 Standout
Cancer survivors and infertility: a review of a new problem and novel answers.
2006
Anthraquinones As Pharmacological Tools and Drugs
2016 Standout
Works of K.-H. Pflüger being referenced
Randomised comparison of CHOEP versus alternating hCHOP/IVEP for high-grade non-Hodgkin's lymphomas: Treatment results and prognostic factor analysis in a multi-centre trial
1994
Altered expression of the human retinoblastoma gene in monocytic leukaemias
1993
Borrelia burgdorferi infection in Europe: An HLA-related disease?
1992
Severe lymphocytopenia and interstitial pneumonia in patients treated with paclitaxel and simultaneous radiotherapy for non-small-cell lung cancer.
1996
Treatment of refractory Hodgkin's disease with high-dose cytosine arabinoside and mitoxantrone in combination. Results of a clinical phase II study of the German Hodgkin study group
1990
Hereditäre Koproporphyrie: Klinische Fehldiagnosen bei akuter hepatischer Porphyrie über ein Dezennium
2008
Treatment with the Gonadotropin-Releasinghormone Agonist Buserelin to Protect Spermatogenesis against Cytotoxic Treatment in Young Men/Behandlung zum Schutz der Spermatogenese bei cytotoxischer Therapie mit dem Gonadotropin-Hormon Agonisten Buserelin
2009